What we do
The principal activities of the Group are the cost effective research and development of medical devices and the more efficient delivery of existing pharmaceuticals with the focus being on sexual healthcare and pain relief management.
Go to Our Company for more information
Who we work with
At Futura, our aim is to develop strong commercial partnerships with world-leading pharmaceutical and healthcare groups which offer the best potential out-licensing opportunities. We currently have agreements with GlaxoSmithKline, Reckitt Benckiser and Ansell.
Go to Our Partners for more information
Our products
We have six products in our development pipeline for sexual healthcare and pain relief management: CSD500, PET500, MED2002, TPR100, TPR100-Rx and RAD100.
Go to Our Products for more information
Futura has developed highly efficient and proprietary delivery technologies: DermaSys® and DermaSys® AquaFree for the absorption of active molecules through the skin.
Go to DermaSys® Technology for more information
